Main content

Date created: | Last Updated:

: DOI | ARK

Creating DOI. Please wait...

Create DOI

Category: Project

Description: We aim to demonstrate the utility of adopting a Bayesian framework to quantify evidential strength and uncertainty for statistical evaluations of benefits of novel cancer drugs at the time of approval. Reanalysing data from the CEIT-Cancer project, we aim to (1) describe evidential strength for clinical trials of drug and biologic products approved for the treatment of cancer in the last two decades; (2) contrast evidential standards between endpoints, accelerated vs. non-accelerated approval, lines of treatment, and type of cancer to describe potential differences in evidential strength.

Files

Loading files...

Citation

Recent Activity

Loading logs...

OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
Accept
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.
Accept
×

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.